Adhesion molecule expression in human hepatic graft-versus-host disease

Area of Science:

• Immunology
• Transplantation Biology
• Cellular Biology

Background:

• Cellular adhesion molecules (ICAM-1, VCAM-1, ELAM-1) play roles in immune responses.
• Graft-versus-host disease (GVHD) involves immune attacks on host tissues after transplantation.
• Understanding adhesion molecule distribution is crucial for diagnosing and managing GVHD.

Purpose of the Study:

• To investigate the distribution of ICAM-1, VCAM-1, and ELAM-1 in normal liver and in liver biopsies from allogeneic bone marrow transplant (BMT) recipients.
• To compare adhesion molecule expression in hepatic GVHD with expression in other GVHD target organs.

Main Methods:

• Immunohistological analysis of liver biopsies.
• Detection of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial-leukocyte adhesion molecule-1 (ELAM-1).
• Comparison between normal liver controls and BMT recipients with and without hepatic GVHD.

Main Results:

• In normal liver, ICAM-1 was on vascular endothelium and sinusoidal cells; VCAM-1 was on Kupffer cells and macrophages. ELAM-1 was largely absent.
• In BMT recipients with hepatic GVHD, ICAM-1 was minimally expressed on damaged bile duct epithelium.
• Increased VCAM-1 positive macrophages were observed in GVHD and non-GVHD liver pathologies, but vascular endothelial expression of VCAM-1 and ELAM-1 did not increase.

Conclusions:

• Adhesion molecule expression patterns in the liver during GVHD differ significantly from those observed in the skin and gastrointestinal tract.
• The limited upregulation of ICAM-1, VCAM-1, and ELAM-1 in the liver may be influenced by biopsy timing, immunosuppressive therapy, or inherent tissue-specific responses.
• These findings highlight potential variations in the cellular and molecular mechanisms of GVHD across different organs.